EGFR and glioma: In fact, the WHO classification of tumors will be updated soon, in 2021, and include the need of analysis for chromosome 7 and loss of whole chromosome 10, and TERT promoter mutation and EGFR amplification for the diagnosis of glioblastoma even though the tumor has histologically low grade glioma features.